Primo wins 2023 TAIPEI Prominent Enterprise Award

Press Releases

We are greatly honored to receive the award of Investment Paradigm from Taipei City Government. Thanks to the Project of Subsidies & Incentives For Taipei Industry, Primo Biotechnology is able to grow faster and take on difficult challenges.

About Primo Biotechnology

Primo Biotechnology is a pioneering leader in Asia’s nuclear medicine sector, dedicated to the development and production of high-precision radiopharmaceuticals. Leveraging molecular imaging technology and innovative therapies, Primo delivers accurate diagnostics and personalized treatments for cancer patients. The company’s vision, Future in Precision, reflects its commitment to advancing healthcare and creating hope for the future. Learn more at www.primobt.com and follow Primo on Facebook and LinkedIn.

About Primo

Primo collaborates with both domestic and international partners to accelerate progress in precision oncology, leveraging its capabilities in drug development, clinical translation, and GMP manufacturing to support next-generation therapeutics. For more information, please follow Primo Biotech on Facebook and LinkedIn.